Episode 77: A New Era of Myasthenia Gravis Treatment

Episode 77 of the NeurologyLive^® Mind Moments^® podcast is now live! Scroll down to listen or click here to subscribe on your favorite streaming service.

The Mind Moments^® podcast features exclusive interviews with leaders in the field discussing the latest research and disease management strategies across the breadth of neurology, including epilepsy, multiple sclerosis, Parkinson disease, dementia, sleep disorders, and more.

Episode 77, "A New Era of Myasthenia Gravis Treatment," features an exclusive interview with George Small, MD, an adult neurologist at Allegheny Health Network, who discussed the state of care for myasthenia gravis and its recent success, the corresponding changes to patient care, and the current era of treatment that the field has entered, among other topics.

This episode is brought to you by Medical World News^™. Check out new episodes of a variety of shows, airing every single day, only on medicalworldnews.com.

The stories featured in this week's Neurology News Minute, which will give you quick updates on the following developments in neurology, are further detailed here:

• Neurosteer Single-Channel EEG Platform Cleared by FDA
• Neurocrine Biosciences Submits Supplemental NDA for Valbenazine in the Treatment of Huntington Disease Chorea
• FDA Refuses to File BrainStorm’s BLA for NurOwn Mesenchymal ALS Therapy
• FDA Accepts NDA for Parkinson Disease Treatment IPX203
• FDA Accepts NDA for Myasthenia Gravis Treatment Zilucoplan

Click here to subscribe to the Mind Moments^® podcast. Be sure to leave a rating and review for the show. Thanks for listening!

Hoping to listen on your favorite podcast app? See below:

• Click here for Apple Podcasts
• Click here for Spotify
• Click here for Google Podcasts